The CESAR trial demonstrated lower mortality and improved outcomes in patients with ARDS who were transferred to an ECMO Center [ 30 ]; the subsequent EOLIA trial showed a trend towards improved outcome with VV-ECMO that was not statistically significant [ 31 ], though a high probability for benefit was indicated in subsequent Bayesian analysis [ 119 ].
← all excerpts
Brain-Lung Crosstalk: Management of Concomitant Severe Acute Brain Injury and Acute Respiratory Distress Syndrome.
1
—
—